Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 15;68(5):865-872.
doi: 10.1093/cid/ciy774.

Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults

Thomas L Holland  1 , Henry F Chambers  2 , Helen W Boucher  3 , G Ralph Corey  1 , Rebecca Coleman  4 , Bibiana Castaneda-Ruiz  4 , Vance G Fowler  1
Affiliations

Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults

Thomas L Holland et al. Clin Infect Dis. .

Abstract

Clinical trials for Staphylococcus aureus bloodstream infections (SAB) are broadly grouped into 2 categories: registrational trials intended to support regulatory approval of antibiotics for the treatment of SAB and strategy trials intended to inform clinicians on the best treatment options for SAB among existing antibiotics. Both types of SAB trials are urgently needed but have been limited by cost, complexity, and regulatory uncertainty. Here, we review key SAB trial design considerations for investigators, sponsors, and regulators.

Keywords: Staphylococcus aureus; bacteremia; clinical trials.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015; 28:603–61. - PMC - PubMed
    1. Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA 2014; 312:1330–41. - PMC - PubMed
    1. US Food and Drug Administration. Guidance for industry. Acute bacterial skin and skin structure infections: developing drugs for treatment. US Department of Health and Human Services, Food and Drug Administration, 2013. Available at: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidan....
    1. Pertel PE, Bernardo P, Fogarty C, et al. . Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia. Clin Infect Dis 2008; 46:1142–51. - PubMed
    1. Paul M, Bishara J, Yahav D, et al. . Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial. BMJ 2015; 350:h2219. - PMC - PubMed

Publication types

MeSH terms

Substances